Skip to main content
SpringerLink
Log in

Facteurs de décisions en radiothérapie

  • Chapter
Diagnostic et décision dans le cancer du sein à un stade précoce

Part of the book series: Collection Oncologie Pratique ((ONCOLPRAT))

  • 304 Accesses

Résumé

Le traitement du cancer du sein a connu ces dernières années de profonds changements, dominé initialement par les nouvelles drogues de chimiothérapie et les thérapies ciblées. La radiothérapie n’est pourtant pas en reste. Outre les facteurs classiques de décision thérapeutique, des outils émergents sont à la disposition du médecin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet Dec 17 366 (9503): 2087–106

    CAS  Google Scholar 

  2. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med Oct 17 347 (16): 1233–41

    Article  Google Scholar 

  3. Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med Oct 17 347 (16): 1227–32

    Article  Google Scholar 

  4. Arriagada R, Mouriesse H, Sarrazin D et al (1985) Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys. 1985 Oct 11 (10): 1751–7

    Article  CAS  Google Scholar 

  5. Bartelink H, Horiot JC, Poortmans P et al (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med Nov 8 345 (19): 1378–87

    CAS  Google Scholar 

  6. Dilhuydy JM, Bussieres E, Romestaing P (2001) [Radiotherapy of the breast and chest wall: treatment volume]. Cancer Radiother Oct 5 (5): 550–9

    Article  CAS  Google Scholar 

  7. Fernando IN, Ford HT, Powles TJ et al (1996) Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 8 (4): 226–33

    Article  CAS  Google Scholar 

  8. Bartelink H, Boersma LJ, Leer JW, Poortmans P (2004) The Intergroup Trial of the BOOG “The Young Boost Trial” BOOG 2004-01; CKTO 2003–13. Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed.

    Google Scholar 

  9. Vicini FA, Horwitz EM, Lacerna MD et al (1997) The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys Dec 1 39 (5): 1069–76

    Article  CAS  Google Scholar 

  10. Harsolia A, Kestin L, Grills I et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys Aug 1 68 (5): 1375–80

    Article  Google Scholar 

  11. Fodor J, Toth J, Major T et al (1999) Incidence and time of occurrence of regional recurrence in stage I–II breast cancer: value of adjuvant irradiation. Int J Radiat Oncol Biol Phys May 1 44 (2): 281–7

    Article  CAS  Google Scholar 

  12. Galper S, Recht A, Silver B et al (1999) Factors associated with regional nodal failure in patients with early stage breast cancer with 0–3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys Dec 1 45 (5): 1157–66

    Article  CAS  Google Scholar 

  13. Wang QE, Zhu Q, Wani MA et al (2003) Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair (Amst) May 13 2 (5): 483–99

    Article  CAS  Google Scholar 

  14. Veronesi U, Marubini E, Del Vecchio M et al (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst Jan 4 87 (1): 19–27

    Article  CAS  Google Scholar 

  15. Taghian AG, Jeong JH, Mamounas EP et al (2006) Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol Aug 20 24 (24): 3927–32

    Google Scholar 

  16. Wallgren A, Bonetti M, Gelber RD et al (2003) Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol Apr 1 21 (7): 1205–13

    CAS  Google Scholar 

  17. Arriagada R, Le MG, Mouriesse H et al (1988) Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. Mar 11 (3): 213–22

    Article  CAS  Google Scholar 

  18. Katz A, Strom EA, Buchholz TA (2001) The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001 Jul 1 50 (3): 735–42

    Article  CAS  Google Scholar 

  19. Hartley AL, Birch JM, Kelsey AM (1989) Are germ cell tumors part of the Li-Fraumeni cancer family syndrome? Cancer Genet Cytogenet Oct 15 42 (2): 221–6

    Article  CAS  Google Scholar 

  20. Recht A, Edge SB, Solin LJ et al (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. Mar 1 19 (5): 1539–69

    CAS  Google Scholar 

  21. Pierce LJ, Oberman HA, Strawderman MH, Lichter AS (1995) Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys Sep 30 33 (2): 253–9

    Article  CAS  Google Scholar 

  22. Ceilley E, Jagsi R, Goldberg S et al (2005) Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys Feb 1 61 (2): 365–73

    Article  Google Scholar 

  23. Elkhuizen PH, van de Vijver MJ, Hermans J (1998) Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys Mar 1 40 (4): 859–67

    Article  CAS  Google Scholar 

  24. Arriagada R, Le MG, Contesso G et al (2002) Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol Sep 13 (9): 1404–13

    Article  CAS  Google Scholar 

  25. Arriagada R, Le MG, Guinebretiere JM et al (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol Nov 14 (11): 1617–22

    Article  CAS  Google Scholar 

  26. Huston TL, Simmons RM (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg Feb 189 (2): 229–35

    Article  Google Scholar 

  27. Clarke DH, Le MG, Sarrazin D et al (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys Jan 11 (1): 137–45

    Article  CAS  Google Scholar 

  28. Fourquet A, Campana F, Zafrani B et al (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys Oct 17 (4): 719–25

    Article  CAS  Google Scholar 

  29. Fisher B, Anderson S, Fisher ER et al (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet Aug 10 338 (8763): 327–31

    CAS  Google Scholar 

  30. Locker AP, Ellis IO, Morgan DA et al (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg Sep 76 (9): 890–4

    Article  CAS  Google Scholar 

  31. Nielsen HM, Overgaard M, Grau C (2006) Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol May 20 24 (15): 2268–75

    Google Scholar 

  32. Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med Oct 2 337 (14): 949–55

    Article  CAS  Google Scholar 

  33. Overgaard M, Jensen MB, Overgaard J et al (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet May 15 353 (9165): 1641–8

    Article  CAS  Google Scholar 

  34. Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in nodepositive premenopausal women with breast cancer. N Engl J Med Oct 2 337 (14): 956–62

    Article  CAS  Google Scholar 

  35. Ragaz J, Olivotto IA, Spinelli JJ et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst Jan 19 97 (2): 116–26

    Article  Google Scholar 

  36. Recht A, Gray R, Davidson NE et al (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol Jun 17 (6): 1689–700

    CAS  Google Scholar 

  37. Katz A, Strom EA, Buchholz TA et al (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol Aug 18 (15): 2817–27

    CAS  Google Scholar 

  38. Taghian A, Jeong JH, Mamounas E et al (2004) Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol Nov 1 22 (21): 4247–54

    Article  Google Scholar 

  39. Karlsson P, Cole BF, Price KN et al (2007) The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer J Clin Oncol May 20 25 (15): 2019–26

    Google Scholar 

  40. Kyndi M, Overgaard M, Nielsen HM et al (2009) High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol Jan 90 (1): 74–9

    Article  Google Scholar 

  41. Tai P, Joseph K, Sadikov E et al (2007) Nodal ratios in node-positive breast cancer—long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy. Int J Radiat Oncol Biol Phys Jul 1 68 (3): 662–6

    Article  Google Scholar 

  42. Woodward WA, Vinh-Hung V, Ueno NT et al (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol Jun 20 24 (18): 2910–6

    Article  Google Scholar 

  43. Truong PT, Berthelet E, Lee J (2005) The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer May 15 103 (10): 2006–14

    Google Scholar 

  44. Joslyn SA, Konety BR (2005) Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat May 91 (1): 11–8

    Article  Google Scholar 

  45. Kyndi M, Sorensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol Mar 20 26 (9): 1419–26

    Article  CAS  Google Scholar 

  46. Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol Apr 9 (4): 331–41

    Article  CAS  Google Scholar 

  47. Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Mar 29 371 (9618): 1098–107

    CAS  Google Scholar 

  48. Whelan T, MacKenzie R, Julian J et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst Aug 7 94 (15): 1143–50

    Article  Google Scholar 

  49. Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med Feb 11 362 (6): 513–20

    CAS  Google Scholar 

  50. Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol Jun 7 (6): 467–71.

    Article  Google Scholar 

  51. Polgar C, Major T, Fodor J et al (2010) Accelerated partial-breast irradiation using high-doserate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol Mar 94 (3): 274–9

    Article  Google Scholar 

  52. Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet Jul 10 376 (9735): 91–102

    Article  Google Scholar 

  53. Vicini F, Beitsch P, Quiet C et al (2010) Five-Year Analysis of Treatment Efficacy and Cosmesis by the American Society of Breast Surgeons Mammosite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys May 14

    Google Scholar 

  54. 54. Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg Aug 209 (2): 269–77

    Article  Google Scholar 

  55. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature. Aug 17 406 (6797): 747–52

    CAS  Google Scholar 

  56. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A Sep 11 98 (19): 10869–74

    Article  CAS  Google Scholar 

  57. Van’’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature Jan 31 415 (6871): 530–6

    Article  Google Scholar 

  58. Paik S, Shak S, Tang G, Kim C et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med Dec 30 351 (27): 2817–26

    Article  CAS  Google Scholar 

  59. Wang Y, Klijn JG, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet Feb 19–25 365 (9460): 671–9

    CAS  Google Scholar 

  60. Chang HY, Nuyten DS, Sneddon JB et al (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A Mar 8 102 (10): 3738–43

    Article  CAS  Google Scholar 

  61. Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med Jan 18 356 (3): 217–26

    Article  CAS  Google Scholar 

  62. Van Beers EH, Nederlof PM (2006) Array-CGH and breast cancer. Breast Cancer Res 8 (3): 210

    Article  PubMed  Google Scholar 

  63. Khodarev NN, Beckett M, Labay E et al (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A Feb 10 101 (6): 1714–9

    Article  CAS  Google Scholar 

  64. Vicini FA, Kestin L, Huang R, Martinez A (2003) Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer Feb 15 97 (4): 910–9

    Google Scholar 

  65. Dragun AE, Pan J, Rai SN et al (2011) Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study. Am J Clin Oncol Jun; 34(3): 231–7

    Article  Google Scholar 

  66. Wang SL, Li YX, Song YW et al (2010) Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients After Mastectomy. Int J Radiat Oncol Biol Phys Jul 15

    Google Scholar 

  67. Solin LJ, Hwang WT, Vapiwala N (2009) Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer May 9 (2): 96–100

    Article  Google Scholar 

  68. Parikh RR, Yang Q, Higgins SA, Haffty BG (2008) Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys Jan 1 70 (1): 35–42

    Article  Google Scholar 

  69. Voduc KD, Cheang MC, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol Apr 1 28(10): 1684–91

    Google Scholar 

  70. Albert JM, Gonzalez-Angulo AM, Guray M et al (2010) Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys Aug 1 77 (5): 1296–302

    Article  CAS  Google Scholar 

  71. Voduc KD, Cheang MC, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol Apr 1 28 (10): 1684–91

    Google Scholar 

  72. Freedman GM, Anderson PR, Li T, Nicolaou N (2009) Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer Mar 1 115 (5): 946–51

    Google Scholar 

  73. Bourgier C, Conforti R, Veillard AS et al (2006) Molecular subclassification and risk of locoregional relapses in early breast cancer patients. San Antonio Breast Cancer Symposium Annual Meeting Personal Communication Abstract 6028

    Google Scholar 

  74. Toledano A, Azria D, Garaud P et al (2007) Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol Feb 1 25 (4): 405–10

    CAS  Google Scholar 

  75. Liang K, Lu Y, Jin W et al (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther Nov 2 (11): 1113–20

    CAS  Google Scholar 

  76. Pietras RJ, Poen JC, Gallardo D (1999) Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res Mar 15 59 (6): 1347–55

    CAS  Google Scholar 

  77. Sambade MJ, Kimple RJ, Camp JT et al (2010) Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. Int J Radiat Oncol Biol Phys Jun 1 77 (2): 575–81

    Article  CAS  Google Scholar 

  78. Sambade MJ, Camp JT, Kimple RJ et al (2009) Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. Radiother Oncol Dec 93 (3): 639–44

    Article  CAS  Google Scholar 

  79. Horton JK, Halle J, Ferraro M et al (2009) Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer with Trastuzumab: A Phase II Trial. Int J Radiat Oncol Biol Phys Jun 26

    Google Scholar 

  80. Collette S, Collette L, Budiharto T et al (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 ‘boost versus no boost’’. Eur J Cancer Nov 44 (17): 2587–99

    Article  Google Scholar 

  81. Ozsahin M, Ozsahin H, Shi Y, Larsson B et al (1997) Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys May 1 38 (2): 429–40

    Article  CAS  Google Scholar 

  82. Crompton NE, Shi YQ, Emery GC et al (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys Feb 1 49 (2): 547–54

    Article  CAS  Google Scholar 

  83. Slonina D, Gasinska A (1997) Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol Dec 72 (6): 693–701

    Article  CAS  Google Scholar 

  84. Azria D, Ozsahin M, Kramar A et al (2008) Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res Oct 1 14 (19): 6284–8

    Article  CAS  Google Scholar 

  85. Ozsahin M, Crompton NE, Gourgou S et al 2005 CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res Oct 15 11 (20): 7426–33

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de radiothérapie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94 800, Villejuif, France

    Céline Bourgier & Steve Heymann

Authors
  1. Céline Bourgier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steve Heymann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Bourgier, C., Heymann, S. (2012). Facteurs de décisions en radiothérapie. In: Diagnostic et décision dans le cancer du sein à un stade précoce. Collection Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0253-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0253-4_6

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0252-7

  • Online ISBN: 978-2-8178-0253-4

Publish with us

Policies and ethics

Search

Navigation